1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 Latin America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa
1.4.4.5 Nigeria
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Siegfried
2.1.1 Business Overview
2.1.2 Buprenorphine Hydrochloride Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Siegfried Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Buprenorphine Hydrochloride Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sanofi Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market Share
2.3 Johnson Matthey
2.3.1 Business Overview
2.3.2 Buprenorphine Hydrochloride Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and
Market Share
2.4 Mallinckrodt
2.4.1 Business Overview
2.4.2 Buprenorphine Hydrochloride Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Price, Revenue, Gross Margin and Market
Share